MARKET

DXR

DXR

DAXOR CORP
NASDAQ
9.20
0.00
0.00%
Opening 09:30 07/17 EDT
OPEN
--
PREV CLOSE
9.20
HIGH
--
LOW
--
VOLUME
0
TURNOVER
--
52 WEEK HIGH
10.15
52 WEEK LOW
7.11
MARKET CAP
44.50M
P/E (TTM)
0.0000
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at DXR last week (0708-0712)?
Weekly Report · 2d ago
Daxor Corporation's BVA-100 Blood Volume Diagnostic Expands To Three New Centers, Gains Traction Nationwide
Daxor Corporation announces expansion of blood volume analysis (BVA) The company's ezBVA Lab service is a state-of-the-art CLIA certified facility that provides on-demand, next day analysis results. Daxor is the global leader in blood volume measurement technology.
Benzinga · 6d ago
Weekly Report: what happened at DXR last week (0701-0705)?
Weekly Report · 07/08 09:59
Weekly Report: what happened at DXR last week (0624-0628)?
Weekly Report · 07/01 09:59
Weekly Report: what happened at DXR last week (0617-0621)?
Weekly Report · 06/24 10:02
Weekly Report: what happened at DXR last week (0610-0614)?
Weekly Report · 06/17 09:58
Weekly Report: what happened at DXR last week (0603-0607)?
Weekly Report · 06/10 09:59
Daxor names John Jefferies as chief medical officer
Healthcare Daxor names John Jefferies as chief medical officer. Jefferies will be a key advisor to help advance the organization's growth objectives. Dax or Corporation (DXR) Stock. Jefferies has been appointed as the company's chief medical officers.
Seeking Alpha · 06/05 12:11
More
About DXR
Daxor Corporation is a blood volume measurement technology company, which is focused on blood volume testing innovation. The Company has developed and marketed the Blood Volume Analyzer (BVA-100), the diagnostic blood test cleared by the food and drug administration (FDA) to provide safe, accurate, objective quantification of blood volume status and composition compared to patient-specific norms. Over 65,000+ tests have been performed at hospital centers across the United States, enhancing hospital performance metrics in a range of surgical and medical conditions, including significantly reducing mortality and readmissions in heart failure and critical care. It is also focused on advancing healthcare by enabling optimal fluid management with blood volume analysis. It has several ongoing trials in the areas of heart failure treatment with support from the National Institutes of Health (NIH) and is under contract developing analyzers.

Webull offers Daxor Corp stock information, including NASDAQ: DXR real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, DXR stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading DXR stock methods without spending real money on the virtual paper trading platform.